Evolution of susceptibility to quinolones of aerobie Gram - Bacilli isolated in an university hospital;Évolution de la sensibilité aux quinolones et aux fluoroquinolones des bacilles à Gram négatif aérobies isolés dans un hôpital universitaire (1992-2000)

Pathologie Biologie

Volumn 50, Issue 1, 2002, Pages 30-37

  Trystram, D ^a   Grenet, K ^a   Cambau, E ^a   Pean Y ^b   Fievet M H ^a   Jarlier, V ^a   Robert, J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

Acinetobacter; Enterobacteriaceae; P. aeruginosa; Quinolones; Resistance

Indexed keywords

BETA LACTAMASE; CIPROFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; 4 QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

AEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DIFFUSION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; UNIVERSITY HOSPITAL; ANTIBIOTIC RESISTANCE; DRUG EFFECT; FRANCE; HOSPITAL BED CAPACITY; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION;

4-QUINOLONES; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FLUOROQUINOLONES; FRANCE; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0036160498     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(01)00264-4     Document Type: Article

References (28)

1. Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: A European collaborative study
2. Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V
3. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin
4. Effect of quinolone use on antimicrobial susceptibility patterns over a 5-year period
5. Resistance to ciprofioxacin appearing during therapy
6. Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones
7. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands
8. Communiqué 2001-2001
9. Automated interpretation of disk diffusion antibiotic susceptibility tests with the radial profile analysis algorithm
10. Trends in the susceptibilities of Proteus mirabilis isolates to quinolones
11. Canadian ofloxacin susceptibility study: A comparative study from 18 medical centers
12. Ofloxacin, a new broad spectrum fluoroquinolone. Results from a multicenter national comparative activity surveillance study
13. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States
14. Crossresistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations
15. The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: A 10 year perspective
16. Fluoroquinolone resistance: Mechanisms and epidemiology
17. Emergence and dissemination of quinolone-resistant Escherichia coli in the community
18. Ten-Year survey of quinolone resistance in Escherichia coli causing urinary tract infections
19. Association with prior fiuoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center
20. Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: Proof provided by typing with a DNA probe
21. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center
22. Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study)
23. Bacterial resistance to ciprofloxacin in Greece: Results from the National Electronic Surveillance System
24. Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of Pseudomonas aeruginosa: A french multicentre study (1996)
25. Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: Focus on ciprofloxacin
26. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries
27. Development of resistance to ciprofloxacin in Acinerobacrer baumannii strains isolated during a 20-month outbreak
28. Characterization of a hospital outbreak of imipenem-resistant Acinerobacter baumannii by phenotypic and genotypic typing methods